09Oct
Caremark Round II: Beware Red Flags in Drug Development
On October 1, 2019, the Delaware Court of Chancery applied the Delaware Supreme Court’s recent decision on Caremark board oversight claims in the context of operating in a highly regulated industry to allow derivative claims to proceed against the...
By:
Goodwin
Source Url: https://www.jdsupra.com/legalnews/caremark-round-ii-beware-red-flags-in-18599/
Related
IR35 was introduced to crack down on perceived tax avoidance whereby individuals would seek to avoid...
Read More >
On July 25, 2019, New Jersey became the latest state to join the movement banning salary history inq...
Read More >
As we advised in June 2019, there was an unprecedented decision by Justice Melissa Crane of the New ...
Read More >
Financial Institutions M&A sector trends: Payments — H1 2020 and outlook for H2 2020. Lockdown uti...
Read More >
For some reason, my unincorporated village doesn’t have a mayor or village board of trustees, but w...
Read More >
It's no longer just bidding! Bricker attorneys Casey Cross and Chris McCloskey will share the risk f...
Read More >